RB1 and neuroendocrine carcinoma: One study endeavored to establish a detailed set of morphologic criteria to separate G3 NET from NEC, with only 1.5% of cases being morphologically ambiguous; however, when these cases were later sequenced, there was discordance in the genetic profiles with the G3 NET group showing RB1 alterations in 30% of cases [18, 19].